Seamless Bioanalytical Transition from Preclinical to Clinical, and Beyond


Seamless Bioanalytical Transition

Altasciences’ scientists move in unison with you, collaboratively, accurately, and efficiently, from preclinical to clinical, and beyond. Our team of over 260 bioanalytical scientific veterans is strategically located across North America, and has experience with a wide spectrum of biological matrices in both animal and humans.
Driven by your assay requirements, our program support includes LC-MS/MS, LBA OR HYBRID LBA/LC-MS/MS ASSAY platforms for:

  • Small molecules
  • Peptides
  • Proteins
  • Antibody-drug conjugates (ADC)
  • Monoclonal antibodies (mAb)
  • Immunogenicity
  • Anti-drug antibody
  • Neutralizing assays
  • Biomarkers — single or packages
  • Oligonucleotides

Speak with a scientist

Have 5 minutes? You may also be interested in the following:

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.